AffyImmune Therapeutics
Robert Forrester has more than two decades of experience serving as chief executive officer or chief financial officer for both private and public biopharma companies. Prior to joining EQRx, Robert was CEO of Verastem Oncology, Chief Operating Officer or Chief Financial Officer at Forma Therapeutics, CombinatoRx (now ZLCS), and Coley Pharmaceutical Group. Robert also served as Managing Director of the Proprietary Investment Group at MeesPierson. He holds a LL.B. from Bristol University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
AffyImmune Therapeutics
AffyImmune Therapeutics is a clinical stage biotechnology company finding safe, effective ways to use CAR T cells against solid cancers.